CLINICAL_TRIALS
trial_result
· 2017-02-06
Clinical Trial Update: A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program [Phase 4]
Summary
Phase 4 expanded-access study of peginterferon alfa-2a in chronic hepatitis B has completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2017-02-06